Journal article icon

Journal article

Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience

Abstract:
Objective: The endocannbinoid system and cannabis exposure has been implicated in emotional processing. The current study examined whether regular cannabis users demonstrated abnormal intrinsic (a.k.a. resting state) frontolimbic connectivity compared to non-users. A secondary aim examined the relationship between cannabis group connectivity differences and self-reported mood and affect symptoms. Method: Participants included 79 cannabis-using and 80 non-using control emerging adults (ages of 18-30), balanced for gender, reading ability, and age. Standard multiple regressions were used to predict if cannabis group status was associated with frontolimbic connectivity after controlling for site, past month alcohol and nicotine use, and days of abstinence from cannabis. Results: After controlling for research site, past month alcohol and nicotine use, and days of abstinence from cannabis, cannabis users demonstrated significantly greater connectivity between left rACC and the following: right rACC (p = 0.001; corrected p = 0.05; f 2 = 0.55), left amygdala (p = 0.03; corrected p = 0.47; f 2 = 0.17), and left insula (p = 0.03; corrected p = 0.47; f 2 = 0.16). Among cannabis users, greater bilateral rACC connectivity was significantly associated with greater subthreshold depressive symptoms (p = 0.02). Conclusions: Cannabis using young adults demonstrated greater connectivity within frontolimbic regions compared to controls. In cannabis users, greater bilateral rACC intrinsic connectivity was associated with greater levels of subthreshold depression symptoms. Current findings suggest that regular cannabis use during adolescence is associated with abnormal frontolimbic connectivity, especially in cognitive control and emotion regulation regions
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/npp.2014.258

Authors

More by this author
Role:
Author
ORCID:
0000-0002-8688-8025
More by this author
Role:
Author
ORCID:
0000-0003-3699-0803
More by this author
Role:
Author
ORCID:
0000-0003-4150-4726
More by this author
Role:
Author
ORCID:
0000-0001-9209-3993
More by this author
Role:
Author
ORCID:
0000-0001-9520-6746


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
Neuropsychopharmacology More from this journal
Volume:
40
Issue:
6
Pages:
1343-1352
Publication date:
2014-09-23
DOI:
EISSN:
1740-634X
ISSN:
0893-133X


Language:
English
Keywords:
Pubs id:
2359316
Local pid:
pubs:2359316
Source identifiers:
W2008435821
Deposit date:
2026-01-15
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP